Levepsy RTU 500 Infusion

Description

Levepsy RTU 500 Infusion

Generic Name: Levetiracetam
Therapeutic Class: Antiepileptic/Anticonvulsant

Uses

• Short-term control of seizures (epilepsy) via intravenous infusion when oral therapy isn’t feasible (e.g., unconscious patients).

• Treats myoclonic, partial-onset, and tonic-clonic seizures.

Key Benefits

• Prevents seizures by slowing abnormal electrical brain activity.

• Improves symptoms like confusion, jerking movements, and loss of awareness.

Dosage & Administration

• Route: IV infusion (slow drip) under medical supervision.

• Duration: Short-term use; transition to oral therapy for long-term control.

• Missed Dose: Administer ASAP. Skip if close to next dose; never double dose.

Side Effects

• Common: Drowsiness, dizziness, headache, irritability, aggression, nasopharyngitis, reduced appetite.

• Serious (Seek Immediate Help):

  • Allergic reactions (swelling, rash, breathing difficulty).

  • Behavioral changes (suicidal thoughts, hostility, confusion).

  • Severe fatigue or infections.

Safety Warnings

• Alcohol: Unsafe (↑ seizures/drowsiness).

• Pregnancy: Potential risk (use only if prescribed).

• Breastfeeding: Likely safe (monitor infant for drowsiness/weight gain).

• Driving/Operating Machinery: Unsafe (may cause dizziness/drowsiness).

• Kidney/Liver Disease: Dose adjustment may be needed (consult doctor).

How It Works

Binds to SV2A protein on nerve cells, stabilizing electrical activity and preventing seizure spread.

Patient Tips

• Do not stop abruptly (may worsen seizures).

• Report mood changes or new/worsening seizures to your doctor.

• Regular kidney function tests may be required.

Note: Always follow your doctor’s instructions. This summary is for informational purposes and does not replace professional medical advice.